TRISHA ALOQUINA: Open Payments
NPI 1972118206 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 10 payments from 6 companies in 2025. Trend: 2023 $468 · 2024 $181 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Amgen Inc. | 1 | $26 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: ELIQUIS, VYNDAQEL, CAMZYOS, WAINUA, REPATHA, FUROSCIX, LEQVIO.
Industry payments across NY — which companies pay providers there.
